CHUGAI PHARMACEUTICAL COCHUGAI PHARMACEUTICAL COCHUGAI PHARMACEUTICAL CO

CHUGAI PHARMACEUTICAL CO

No trades
See on Supercharts

4519 fundamentals

CHUGAI PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4519 for the last quarter is 236.95 B JPY, and it's 13.46% lower compared to the previous quarter. The net income of Q1 24 is 74.40 B JPY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: JPY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth